Wells Fargo analyst issues OVERWEIGHT recommendation for WVE on May 20, 2026 10:29AM ET. The previous analyst recommendation was Overweight.WVE was trading at $6.14 at issue of the analyst recommendation.The...
KeyBanc analyst issues OVERWEIGHT recommendation for CYRX on May 20, 2026 10:24AM ET. The previous analyst recommendation was Overweight.CYRX was trading at $13.03 at issue of the analyst recommendation.The overall...
Wells Fargo analyst issues OVERWEIGHT recommendation for GOOGL on May 20, 2026 10:33AM ET. The previous analyst recommendation was Overweight.GOOGL was trading at $387.66 at issue of the analyst recommendation.The...
Wells Fargo analyst issues OVERWEIGHT recommendation for KEYS on May 20, 2026 10:30AM ET. The previous analyst recommendation was Overweight.KEYS was trading at $343.99 at issue of the analyst recommendation.The...
Jefferies analyst issues HOLD recommendation for SMGZY on May 20, 2026 10:21AM ET. The previous analyst recommendation was Hold.SMGZY was trading at $33.27 at issue of the analyst recommendation.The overall...
Wells Fargo analyst issues OVERWEIGHT recommendation for META on May 20, 2026 10:34AM ET. The previous analyst recommendation was Overweight.META was trading at $602.61 at issue of the analyst recommendation.The...
Wells Fargo analyst issues OVERWEIGHT recommendation for MRVL on May 20, 2026 10:35AM ET. The previous analyst recommendation was Overweight.MRVL was trading at $176.27 at issue of the analyst recommendation.The...
Morgan Stanley analyst issues OVERWEIGHT recommendation for ZTO on May 20, 2026 10:48AM ET. The previous analyst recommendation was Overweight.ZTO was trading at $23.55 at issue of the analyst recommendation.The...
Piper Sandler analyst issues NEUTRAL recommendation for DRVN on May 20, 2026 10:47AM ET. The previous analyst recommendation was Neutral.DRVN was trading at $13.23 at issue of the analyst recommendation.The...
Piper Sandler analyst issues OVERWEIGHT recommendation for DRUG on May 20, 2026 10:44AM ET. The previous analyst recommendation was Overweight.DRUG was trading at $74.54 at issue of the analyst recommendation.The...
